Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Oxford Biomedica (OXB) Share News

SMALL-CAP WINNERS & LOSERS: Capita buoyed by contract win and disposal

16th Sep 2022 10:51

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Friday. Read More

Oxford BioMedica swings to interim loss as costs climb, revenue falls

15th Sep 2022 10:16

(Alliance News) - Oxford BioMedica PLC on Thursday reported a swing to interim loss and a decline in interim revenue. Read More

IN BRIEF: Oxford BioMedica subsidiary signs deal with new partner

14th Sep 2022 09:57

Oxford BioMedica PLC - Oxford, England-based gene and cell therapy company - Says subsidiary Oxford Biomedica Solutions LLC has signed a deal with an unnamed new partner, for an undisclosed sum. Says the deal gives the US-based, private biotechnology firm access to Oxford BioMedica Solutions's process and manufacturing platform. Read More

UK earnings, trading statements calendar - next 7 days

8th Sep 2022 16:00

Oxford BioMedica shares up as license deal signed with new US partner

7th Sep 2022 09:12

(Alliance News) - Oxford BioMedica PLC on Wednesday said it signed a license and supply agreement with an unnamed new partner. Read More

EXECUTIVE CHANGES: ReNeuron promotes CFO Catherine Isted to CEO role

1st Aug 2022 14:30

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Monday and not separately reported by Alliance News: Read More

SMALL-CAP WINNERS & LOSERS: Reach and Wickes sink on dark outlook

26th Jul 2022 11:12

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Tuesday. Read More

Oxford BioMedica begins new project and signs license agreement

26th Jul 2022 11:09

(Alliance News) - Oxford BioMedica PLC on Tuesday said it started a new project and signed a license and supply agreement. Read More

SMALL-CAP WINNERS & LOSERS: Made.com and Hochschild slide again

22nd Jul 2022 10:36

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Friday. Read More

IN BRIEF: Oxford BioMedica shares up on deal expansion in CAR-T

21st Jul 2022 11:13

Oxford BioMedica PLC - Oxford, England-based gene and cell therapy company - Expands its license and clinical supply agreement with Juno Therapeutics Inc, subsidiary of New-York based pharmaceutical industry company Bristol Myers Squibb. It says the expansion relates to the start of two new viral vector programmes for CAR-T therapies. "Oxford Biomedica will receive an undisclosed target nomination fee and potential payments upon the achievement of certain milestones," it notes. Read More

SMALL-CAP WINNERS & LOSERS: Go-Ahead suitor pulls out; Costain rises

21st Jul 2022 10:28

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Thursday. Read More

SMALL-CAP WINNERS & LOSERS: Oxford BioMedica rises on AstraZeneca deal

1st Jul 2022 10:41

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Friday. Read More

LONDON MARKET OPEN: Recession fear hits stocks; Oxford Biomedica rises

1st Jul 2022 08:56

(Alliance News) - Stocks in London opened lower on Friday as investors continued to fret over prospects of a recession as central banks raise interest rates. Read More

Oxford BioMedica signs new Covid-19 vaccine deal with AstraZeneca

1st Jul 2022 08:31

(Alliance News) - Oxford BioMedica PLC on Friday said it has signed a new three year agreement with AstraZeneca PLC, which will facilitate potential future manufacturing opportunities for the FTSE 100-listed drugmaker's Covid-19 vaccine. Read More

LONDON BRIEFING: Oxford Biomedica signs new Covid jab deal with Astra

1st Jul 2022 08:07

(Alliance News) - Oxford Biomedica on Friday said that it has signed a new three-year agreement with AstraZeneca, which would facilitate potential future manufacturing opportunities for the FTSE 100-listed drugmaker's Covid-19 vaccine. Read More

LONDON MARKET PRE-OPEN: Oxford Biomedica inks new AstraZeneca jab deal

1st Jul 2022 07:48

(Alliance News) - Stock prices in London are seen opening lower on Friday following another sell-off on Wall Street fuelled by recession fears, while focus will be on a slew of manufacturing PMI readings later in the day. Read More

US FDA lifts clinical hold on Oxford BioMedica partner's trial

14th Jun 2022 11:16

(Alliance News) - Oxford BioMedica PLC on Tuesday noted that the US Food & Drug Administration lifted the clinical hold on Homology Medicines Inc's pheNIX gene therapy trial. Read More

TOP NEWS: Centrica warms up for FTSE 100 as Royal Mail sent packing

1st Jun 2022 18:21

(Alliance News) - FTSE Russell confirmed on Wednesday that the following changes will take effect to its UK indices from the market open on Monday, June 20 after completing its quarterly review. Read More

Centrica and Johnson Matthey indicated to join FTSE 100, Asos in 250

25th May 2022 10:18

(Alliance News) - British Gas-owner Centrica PLC and chemical firm Johnson Matthey PLC are set to return to the FTSE 100 index next month, replacing television broadcaster ITV PLC and postal operator Royal Mail PLC, according to indicative changes released by FTSE Russell on Tuesday. Read More

UK shareholder meetings calendar - next 7 days

20th May 2022 16:00

FTSE 100 Latest

Value8,809.74

Change53.53